In This Issue.
- Published in:
- International Immunology, 2022, v. 34, n. 3, p. 129, doi. 10.1093/intimm/dxac003
- Publication type:
- Article
Works matching IS 09538178 AND DT 2022 AND VI 34 AND IP 3
Results: 5
1
2
Transcription factor MafB-mediated inhibition of type I interferons in plasmacytoid dendritic cells.
- Published in:
- International Immunology, 2022, v. 34, n. 3, p. 159, doi. 10.1093/intimm/dxab103
- By:
- Publication type:
- Article
3
MR1, an immunological periscope of cellular metabolism.
- Published in:
- International Immunology, 2022, v. 34, n. 3, p. 141, doi. 10.1093/intimm/dxab101
- By:
- Publication type:
- Article
4
DNAM-1 promotes inflammation-driven tumor development via enhancing IFN-γ production.
- Published in:
- International Immunology, 2022, v. 34, n. 3, p. 149, doi. 10.1093/intimm/dxab099
- By:
- Publication type:
- Article
5
Pharmacological effects on anaplerotic pathways alter the metabolic landscape in the tumor microenvironment, causing unpredictable, sustained anti-tumor immunity.
- Published in:
- International Immunology, 2022, v. 34, n. 3, p. 133, doi. 10.1093/intimm/dxab067
- By:
- Publication type:
- Article